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Leishmaniasis is a chronic infection in which intracellular parasites avoid destruction by the immune system.
Using intravital imaging, Filipe-Santos et al. (2009) demonstrate that some parasitized dendritic cells receive
much less attention than others during their choreographed dance with T cells, suggesting that these ‘‘wall-
flowers’’ could allow for parasite survival.The control of intracellular pathogens
by cell-mediated immunity is primarily me-
diated by interferon (IFN)-g-producing
Tcells,which in turnactivatemacrophages
to enhance microbicidal activity. More
than25yearsof in vitro studieshaveshown
how effective this pathway can be at
controlling many intracellular pathogens.
However, whether this in vitro model reca-
pitulates what is occurring in vivo is un-
known.
With the development of multiphoton
confocal microscopy, it is now possible
to image live tissues, allowing us to see
how cells of the immune system behave
in an in vivo setting. Such imaging has led
to a better understanding of how T cells
interact with antigen-presenting cells in
a variety of tissues (Germain et al., 2008).
One of the most interesting aspects of
these studies was the finding that naive
T cells undergo a choreographed dance
when interacting with dendritic cells pre-
senting their cognate antigen. Intravital
imaging is being used to define how
effector T cells respond during infection
with intracellular pathogens, such as
Toxoplasma,Listeria,Mycobacterium, and
lymphocytic choriomeningitis virus (Aoshi
et al., 2008; Egen et al., 2008; Kim et al.,
2009; Schaeffer et al., 2009; Wilson et al.,
2009). Now, using intravital imaging,
Bousso and colleagues (Filipe-Santos
et al., 2009) have examined the interac-
tions between T cells, Leishmania major
parasites and host cells, and identified
roadblocks that may limit the efficacy of
the T cell response.
Infection of mice with L. major leads to
the development of cutaneous lesions
that resolve in C57BL/6 mice, but in
BALB/c mice results in an uncontrolled
and eventually fatal infection. The differ-
ence in outcome is directly tied to the
development of a strong CD4+ Th1response. However, even once a Th1 re-
sponse is established it can take many
weeks before C57BL/6 mice resolve their
infections—and they never eliminate all of
the parasites. Recently, intravital imaging
has provided some unexpected views of
how a Leishmania infection is initiated.
For example, the entry of L. major into
dendritic cells is not a passive event on
the part of the dendritic cell, as these cells
can be seen actively extending dendrites
to capture the parasites (Ng et al., 2008).
Intravital imaging also helped demon-
strate that the large number of neutro-
phils rapidly invading the infection site
following sand fly transmission is crucial
for establishing the infection (Peters
et al., 2008). Now Bousso and colleagues
have used intravital imaging to better un-
derstand how effector T cells recognize
infected cells within leishmanial lesions.
Using a lysozyme reporter mouse (Lys-
EGFP) and DsRed-labeled L. major para-
sites, Bousso and colleagues (Filipe-San-
tos et al., 2009) showed that CD11b+
CD11c+Lys-EGFP+MHC+ cells were the
primary host cell infected with L. major in
cutaneous lesions. While this confirms
other recent studies (De Trez et al.,
2009), the identification of MHC class II
expression on the infected cells reveals
the potential for recognition by antigen-
specific T cells. The authors then took
advantage of a T cell receptor transgenic
mouse (WT15) in which T cells recognize
the leishmanial antigen, LACK. In this
study, LACK-specific T cells were acti-
vated in the presence of interleukin-12 to
promote a Th1 phenotype, dye-labeled,
and transferred into L. major-infected
mice and visualized. Surprisingly, T cells
appeared to be differentially attracted to
their potential partners, with T cells estab-
lishing prolonged contacts with some
infected cells, while failing to maintainCell Host & Miccontact with others. Although this be-
havior could be due to heterogeneity in
the activation status of the T cells, the
authors favor the idea that variable levels
of peptide-MHC complexes on infected
cells contribute to the preferred partner
selection by T cells. All infected cells
were found to be CD11b+CD11c+ de-
ndritic cells, ruling out the possibility
that T cells prefer a unique subset of
L. major-infected cells. To confirm that
partner selection between WT15 T cells
and parasite-infected cells relied on
T cell specificity, polyclonal T cells were
also transferred into infectedmice. In con-
trast toWT15 cells, few of these T cells in-
teracted with infected cells. Moreover,
while polyclonal T cells were evenly dis-
tributed throughout the tissue, WT15 cells
were preferentially enriched in areas of
infected cells (Figure 1). However, there
were also areas of the lesion that con-
tained parasites, but no T cells (Figure 1).
This latter observation suggests that in
addition to limited dance time between
the infected cells and T cells, some in-
fected cells may sit out the dance entirely,
thus potentially providing safe havens for
the parasite within the lesion.
Taken together, these findings suggest
that the orchestrated dance between
T cells and dendritic cells is not uniform
and that T cells preferentially select some
infected dendritic cells for prolonged in-
teraction, while virtually ignoring others.
What is less clear is whether such pro-
longed interactions between effector
T cells and antigen-presenting cells are
required for the production of IFN-g, and
subsequently for the induction of nitric
oxide production required for parasite
destruction. A recent study found that
only about 25% of infected cells within
leishmanial lesionsexpress induciblenitric
oxide synthase (iNOS) (De Trez et al., 2009),robe 6, July 23, 2009 ª2009 Elsevier Inc. 3
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PreviewsFigure 1. T Cell Interactions with Infected Cells in Leishmanial Lesions
Antigen-specific (red) and nonspecific T cells (gray) enter leishmanial lesions from the blood with similar
frequency [1], but once in the lesions, behave differently. T cells recognizing Leishmania are found in higher
frequency in areas where infected CD11b+, CD11c+ dendritic cells (DCs) are located when compared to
nonspecific T cells [2]. Some antigen-specific T cells are in contact with infected DCs, while others only
transiently scan the infected cells. Other regions with infected DCs exclude T cells altogether [3].and it is tempting to speculate that these are
the cells that received more attention from
theeffectorTh1cells. If that is thecase, these
findings may in part explain why it takes so
long after an immune response is initiated
to resolve cutaneous lesions. Future studies
to define the type of interaction required for
a T cell to induce iNOS production by
infected dendritic cells may help us to better4 Cell Host & Microbe 6, July 23, 2009 ª2009understand why L. major is so often associ-
ated with chronic infections.
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